| Code | Description | Claims | Beneficiaries | Total Paid |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
125,848 |
107,900 |
$7.87M |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
190,425 |
158,628 |
$3.77M |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
191,009 |
159,136 |
$3.65M |
| 80053 |
Comprehensive metabolic panel |
531,474 |
467,525 |
$2.18M |
| 80061 |
Lipid panel |
424,276 |
366,101 |
$2.16M |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
126,086 |
108,193 |
$1.95M |
| 84443 |
Thyroid stimulating hormone (TSH) |
306,482 |
266,053 |
$1.86M |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
167,212 |
141,783 |
$1.84M |
| 80050 |
General health panel |
93,510 |
78,577 |
$1.77M |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
53,181 |
43,168 |
$1.71M |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
88,203 |
74,706 |
$1.50M |
| 80081 |
|
25,070 |
21,565 |
$1.44M |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
449,260 |
386,778 |
$1.41M |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
49,906 |
42,598 |
$1.24M |
| 83036 |
Hemoglobin; glycosylated (A1C) |
307,954 |
262,960 |
$1.05M |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
74,699 |
63,581 |
$1.03M |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
64,599 |
57,187 |
$965K |
| 80074 |
|
39,618 |
31,885 |
$700K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
20,438 |
19,155 |
$689K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
98,837 |
19,198 |
$667K |
| 86003 |
|
214,914 |
12,063 |
$662K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
161,035 |
137,490 |
$641K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
19,710 |
16,056 |
$549K |
| 82607 |
|
85,215 |
73,302 |
$505K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
3,065 |
2,831 |
$475K |
| 87481 |
|
66,220 |
10,364 |
$458K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
3,125 |
2,312 |
$452K |
| 80055 |
|
14,727 |
12,659 |
$442K |
| 81514 |
|
4,123 |
3,733 |
$437K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
4,324 |
3,877 |
$405K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
12,475 |
9,029 |
$374K |
| 86803 |
|
51,730 |
44,256 |
$347K |
| 81513 |
|
8,006 |
7,066 |
$345K |
| 84439 |
|
91,127 |
77,969 |
$336K |
| 87077 |
|
68,050 |
59,961 |
$316K |
| 82728 |
|
58,436 |
50,088 |
$301K |
| 87902 |
|
3,223 |
2,874 |
$295K |
| 84403 |
|
24,851 |
21,623 |
$288K |
| 88142 |
|
26,983 |
23,320 |
$283K |
| 81511 |
|
17,593 |
10,515 |
$275K |
| 82746 |
|
48,675 |
41,675 |
$270K |
| 86696 |
|
23,258 |
20,216 |
$260K |
| 84702 |
|
39,561 |
28,088 |
$257K |
| 87081 |
|
56,225 |
49,217 |
$252K |
| 87536 |
|
8,252 |
7,375 |
$248K |
| 87522 |
Neg quan hep c or qual rna |
13,060 |
11,489 |
$246K |
| 86592 |
|
98,793 |
85,628 |
$245K |
| 83970 |
|
22,224 |
19,678 |
$244K |
| 83655 |
|
31,333 |
28,587 |
$221K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
70,851 |
61,224 |
$220K |
| 83550 |
|
62,198 |
53,603 |
$219K |
| 83880 |
|
17,950 |
15,228 |
$218K |
| 86038 |
|
35,782 |
30,822 |
$215K |
| 85027 |
|
81,671 |
70,346 |
$209K |
| 84153 |
|
29,699 |
25,217 |
$207K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
5,882 |
5,378 |
$196K |
| 83540 |
|
74,004 |
63,292 |
$192K |
| 87186 |
|
48,052 |
42,395 |
$189K |
| 84481 |
|
23,901 |
20,882 |
$184K |
| 82670 |
|
12,756 |
11,348 |
$181K |
| 36415 |
Collection of venous blood by venipuncture |
332,717 |
259,478 |
$179K |
| 87340 |
|
34,678 |
28,722 |
$177K |
| 82105 |
|
18,225 |
15,425 |
$175K |
| 87480 |
|
20,392 |
16,078 |
$174K |
| 88141 |
|
15,690 |
13,235 |
$166K |
| 86695 |
|
21,863 |
19,088 |
$163K |
| 86480 |
|
8,190 |
7,071 |
$163K |
| 83013 |
|
5,938 |
5,435 |
$162K |
| 86235 |
|
36,771 |
5,825 |
$158K |
| 83001 |
|
15,040 |
13,324 |
$153K |
| 82570 |
|
81,545 |
68,974 |
$145K |
| 83735 |
|
57,098 |
48,066 |
$138K |
| 87510 |
|
16,969 |
12,931 |
$134K |
| 84146 |
|
12,619 |
11,003 |
$131K |
| 86762 |
|
15,802 |
12,730 |
$128K |
| 83020 |
|
17,693 |
14,121 |
$127K |
| 84480 |
|
22,787 |
19,633 |
$125K |
| 87660 |
|
17,410 |
12,554 |
$124K |
| 81420 |
Fetal chromosomal aneuploidy genomic sequence analysis panel |
427 |
388 |
$123K |
| 82785 |
|
13,978 |
8,800 |
$118K |
| 84270 |
|
10,735 |
9,423 |
$118K |
| 83002 |
|
11,348 |
10,015 |
$114K |
| 84144 |
|
10,190 |
8,553 |
$113K |
| 86665 |
|
8,980 |
4,237 |
$113K |
| 83525 |
|
16,552 |
14,679 |
$110K |
| 87070 |
|
23,688 |
20,116 |
$109K |
| 82043 |
|
55,765 |
49,364 |
$106K |
| 82677 |
|
6,195 |
5,371 |
$104K |
| 86703 |
|
10,827 |
9,454 |
$101K |
| 87799 |
|
18,574 |
2,222 |
$99K |
| 86769 |
|
4,735 |
3,858 |
$95K |
| 84436 |
|
36,087 |
30,120 |
$90K |
| 87511 |
|
7,900 |
6,054 |
$88K |
| 86376 |
|
11,767 |
10,334 |
$87K |
| 81001 |
|
66,457 |
57,316 |
$86K |
| 86140 |
|
38,278 |
32,734 |
$83K |
| 80164 |
|
14,243 |
11,859 |
$81K |
| 84550 |
|
39,426 |
34,323 |
$81K |
| 86850 |
|
16,711 |
13,427 |
$80K |
| 80076 |
|
24,647 |
20,936 |
$76K |
| 83516 |
|
23,069 |
6,907 |
$71K |
| 86431 |
|
26,248 |
22,826 |
$71K |
| 87507 |
|
344 |
275 |
$69K |
| 82950 |
|
22,251 |
19,914 |
$69K |
| 82248 |
|
30,153 |
25,469 |
$69K |
| 86336 |
|
6,211 |
5,373 |
$67K |
| 86787 |
|
8,429 |
6,862 |
$67K |
| 87631 |
|
799 |
712 |
$65K |
| 86360 |
|
4,681 |
4,090 |
$64K |
| 85652 |
|
47,900 |
41,618 |
$60K |
| 82784 |
|
22,033 |
7,380 |
$59K |
| 84681 |
|
7,171 |
6,352 |
$58K |
| 83690 |
|
16,363 |
14,372 |
$56K |
| 87653 |
|
2,607 |
2,221 |
$56K |
| 82627 |
|
4,300 |
3,869 |
$55K |
| 86359 |
|
4,691 |
4,097 |
$54K |
| 87512 |
|
3,717 |
1,662 |
$53K |
| 86800 |
|
6,876 |
6,025 |
$53K |
| 86706 |
|
11,091 |
9,342 |
$50K |
| 82652 |
|
3,452 |
2,936 |
$49K |
| 85660 |
|
11,200 |
9,700 |
$48K |
| 80177 |
|
7,632 |
6,613 |
$46K |
| 80349 |
|
5,279 |
3,559 |
$46K |
| 82150 |
|
13,709 |
11,971 |
$45K |
| 86225 |
|
9,685 |
7,201 |
$45K |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
4,873 |
4,393 |
$45K |
| 87147 |
|
12,194 |
10,841 |
$44K |
| 86780 |
|
3,803 |
3,279 |
$43K |
| 87209 |
|
3,683 |
3,251 |
$43K |
| 86160 |
|
14,512 |
5,843 |
$42K |
| 84156 |
|
28,531 |
24,091 |
$41K |
| 80361 |
|
4,490 |
2,612 |
$41K |
| 84479 |
|
18,797 |
15,938 |
$41K |
| 86039 |
|
8,608 |
7,055 |
$41K |
| 82533 |
|
5,234 |
4,174 |
$41K |
| 82550 |
|
16,275 |
13,855 |
$41K |
| 84238 |
|
3,570 |
3,299 |
$40K |
| 83615 |
|
12,406 |
10,379 |
$40K |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
415 |
387 |
$40K |
| 86200 |
|
7,308 |
6,083 |
$38K |
| 85610 |
|
26,109 |
19,871 |
$38K |
| 82947 |
|
16,735 |
13,986 |
$38K |
| 86664 |
|
3,286 |
2,894 |
$37K |
| 86704 |
|
7,855 |
6,725 |
$37K |
| 86677 |
|
4,541 |
3,604 |
$37K |
| 86147 |
|
4,665 |
1,746 |
$36K |
| 87205 |
|
14,717 |
12,850 |
$36K |
| 87255 |
|
1,841 |
1,597 |
$35K |
| 88342 |
|
1,417 |
930 |
$34K |
| 88112 |
|
1,964 |
1,762 |
$34K |
| 87451 |
|
15,815 |
4,591 |
$34K |
| 83021 |
|
3,450 |
3,134 |
$33K |
| 86901 |
|
15,241 |
12,124 |
$33K |
| 82951 |
|
4,836 |
4,369 |
$32K |
| 84165 |
|
11,294 |
9,280 |
$31K |
| 80069 |
|
13,651 |
11,820 |
$31K |
| 88307 |
|
610 |
441 |
$31K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,766 |
2,373 |
$31K |
| 86663 |
|
3,089 |
2,721 |
$31K |
| 87427 |
|
4,506 |
4,016 |
$31K |
| 82378 |
|
4,195 |
3,445 |
$29K |
| 87045 |
|
4,560 |
4,076 |
$29K |
| 86334 |
|
5,797 |
4,613 |
$29K |
| 82024 |
|
1,584 |
1,361 |
$27K |
| 80185 |
|
5,255 |
4,397 |
$27K |
| 86694 |
|
3,123 |
2,854 |
$26K |
| 83521 |
|
2,816 |
1,350 |
$26K |
| 86900 |
|
15,258 |
12,127 |
$24K |
| 84100 |
|
15,349 |
12,511 |
$23K |
| 86146 |
|
2,301 |
993 |
$23K |
| 85018 |
|
14,887 |
13,642 |
$23K |
| 87529 |
|
1,289 |
825 |
$23K |
| 82565 |
|
11,176 |
8,693 |
$22K |
| 81596 |
|
884 |
789 |
$21K |
| 87177 |
|
3,707 |
3,275 |
$21K |
| 86361 |
|
2,911 |
2,547 |
$21K |
| 83520 |
|
4,773 |
3,013 |
$20K |
| G0123 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision |
2,540 |
2,335 |
$20K |
| 85014 |
|
12,898 |
12,017 |
$20K |
| 85045 |
|
10,709 |
9,438 |
$20K |
| 84703 |
|
4,786 |
4,352 |
$20K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
11,264 |
9,463 |
$20K |
| 80178 |
|
7,471 |
6,030 |
$20K |
| 84445 |
|
915 |
840 |
$20K |
| 87632 |
|
219 |
209 |
$20K |
| 86618 |
|
2,378 |
1,986 |
$19K |
| 80197 |
|
3,510 |
2,700 |
$19K |
| 85730 |
|
9,412 |
7,321 |
$19K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
318 |
269 |
$19K |
| 87276 |
|
2,036 |
1,783 |
$18K |
| 87046 |
|
4,573 |
4,084 |
$18K |
| 86757 |
|
2,152 |
1,057 |
$18K |
| 86258 |
|
1,848 |
1,091 |
$17K |
| 86705 |
|
2,772 |
2,467 |
$17K |
| 87493 |
|
548 |
505 |
$17K |
| 87275 |
|
2,037 |
1,784 |
$16K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
563 |
508 |
$16K |
| 83090 |
|
2,048 |
1,758 |
$16K |
| 82977 |
|
5,654 |
4,722 |
$16K |
| 86708 |
|
2,857 |
2,465 |
$16K |
| 86304 |
|
2,267 |
1,695 |
$16K |
| 86255 |
|
2,279 |
1,398 |
$16K |
| 84207 |
|
1,892 |
1,611 |
$15K |
| 84425 |
|
1,876 |
1,665 |
$15K |
| 84460 |
|
6,793 |
5,771 |
$15K |
| 85379 |
|
3,795 |
3,427 |
$15K |
| 82140 |
|
2,969 |
2,499 |
$14K |
| 84520 |
|
7,058 |
5,437 |
$14K |
| 86364 |
|
1,749 |
1,580 |
$14K |
| 84450 |
|
6,568 |
5,537 |
$13K |
| 83883 |
|
4,306 |
1,507 |
$13K |
| 86709 |
|
1,807 |
1,639 |
$13K |
| 82465 |
|
6,353 |
5,455 |
$13K |
| 80156 |
|
2,284 |
1,994 |
$12K |
| 87563 |
|
674 |
652 |
$12K |
| 82330 |
|
3,047 |
2,695 |
$12K |
| 81329 |
|
207 |
198 |
$12K |
| 87075 |
|
3,640 |
2,998 |
$11K |
| 87449 |
|
2,077 |
1,827 |
$11K |
| 86141 |
|
1,817 |
1,561 |
$11K |
| 80346 |
|
3,172 |
1,523 |
$11K |
| 88164 |
|
2,051 |
1,862 |
$11K |
| 80175 |
|
1,555 |
1,347 |
$10K |
| 82088 |
|
613 |
546 |
$10K |
| 87517 |
|
683 |
592 |
$10K |
| 88304 |
|
877 |
730 |
$10K |
| 87015 |
|
2,680 |
2,261 |
$10K |
| 84466 |
|
2,347 |
1,968 |
$10K |
| 85060 |
|
2,436 |
1,920 |
$10K |
| 87324 |
|
1,777 |
1,571 |
$10K |
| 82247 |
|
3,927 |
2,856 |
$9K |
| 86300 |
|
2,147 |
1,170 |
$9K |
| 83721 |
|
2,558 |
2,125 |
$9K |
| 87901 |
|
118 |
107 |
$9K |
| 81025 |
|
1,956 |
1,622 |
$9K |
| 84134 |
|
1,987 |
1,502 |
$8K |
| 86008 |
|
3,597 |
1,194 |
$8K |
| 86308 |
|
1,921 |
1,733 |
$8K |
| 80183 |
|
717 |
623 |
$8K |
| 84132 |
|
3,838 |
3,267 |
$8K |
| 83921 |
|
1,103 |
1,016 |
$8K |
| 82952 |
|
3,212 |
2,903 |
$8K |
| 80365 |
|
2,217 |
964 |
$8K |
| 83498 |
|
632 |
590 |
$7K |
| 82671 |
|
553 |
495 |
$7K |
| 86593 |
|
2,680 |
2,333 |
$7K |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
131 |
92 |
$7K |
| 86231 |
|
844 |
766 |
$7K |
| 84155 |
|
7,927 |
6,251 |
$7K |
| 86812 |
|
656 |
599 |
$7K |
| 80324 |
|
1,333 |
638 |
$7K |
| 86036 |
|
896 |
499 |
$6K |
| 84484 |
|
1,482 |
1,283 |
$6K |
| 83010 |
|
1,578 |
1,316 |
$6K |
| 81003 |
|
7,919 |
6,392 |
$6K |
| 87102 |
|
1,541 |
1,326 |
$6K |
| 85007 |
|
4,146 |
3,396 |
$6K |
| 83695 |
|
1,072 |
901 |
$6K |
| 86015 |
|
575 |
502 |
$6K |
| 84432 |
|
838 |
775 |
$5K |
| 82668 |
|
1,037 |
962 |
$5K |
| 80364 |
|
872 |
453 |
$5K |
| 87206 |
|
2,441 |
1,822 |
$5K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
107 |
102 |
$5K |
| 82626 |
|
428 |
386 |
$5K |
| 82542 |
|
437 |
409 |
$5K |
| 83698 |
|
305 |
277 |
$5K |
| 83704 |
|
282 |
275 |
$5K |
| 80326 |
|
863 |
555 |
$5K |
| 86886 |
|
1,774 |
1,542 |
$5K |
| 80159 |
|
945 |
710 |
$5K |
| 80184 |
|
1,298 |
1,072 |
$5K |
| 87280 |
|
489 |
453 |
$5K |
| 80353 |
|
1,384 |
605 |
$4K |
| 80202 |
|
981 |
439 |
$4K |
| 82274 |
|
694 |
550 |
$4K |
| 87338 |
|
730 |
670 |
$4K |
| 84630 |
|
1,046 |
950 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
464 |
382 |
$4K |
| 82397 |
|
753 |
658 |
$4K |
| 85240 |
|
490 |
416 |
$4K |
| G0432 |
Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening |
604 |
229 |
$4K |
| 86381 |
|
439 |
381 |
$4K |
| P3001 |
Screening papanicolaou smear, cervical or vaginal, up to three smears, requiring interpretation by physician |
750 |
672 |
$4K |
| 87273 |
|
845 |
440 |
$4K |
| 81015 |
|
4,117 |
3,247 |
$4K |
| 87088 |
|
781 |
666 |
$3K |
| 82040 |
|
1,749 |
1,502 |
$3K |
| 85613 |
|
1,162 |
865 |
$3K |
| 86341 |
|
402 |
296 |
$3K |
| 82232 |
|
1,039 |
818 |
$3K |
| 84075 |
|
1,813 |
1,515 |
$3K |
| P3000 |
Screening papanicolaou smear, cervical or vaginal, up to three smears, by technician under physician supervision |
471 |
457 |
$3K |
| 84080 |
|
713 |
630 |
$3K |
| 80162 |
|
1,021 |
840 |
$3K |
| 82172 |
|
312 |
267 |
$3K |
| 84295 |
|
1,577 |
1,267 |
$3K |
| 80348 |
|
3,094 |
1,062 |
$3K |
| 86301 |
|
450 |
330 |
$3K |
| 86666 |
|
629 |
289 |
$3K |
| 84244 |
|
290 |
273 |
$3K |
| 80362 |
|
500 |
459 |
$3K |
| 86335 |
|
301 |
266 |
$3K |
| 80356 |
|
656 |
555 |
$3K |
| 84305 |
|
211 |
195 |
$2K |
| 82310 |
|
1,581 |
1,326 |
$2K |
| 80354 |
|
1,159 |
550 |
$2K |
| 82610 |
|
165 |
143 |
$2K |
| 87040 |
|
747 |
392 |
$2K |
| 87350 |
|
314 |
281 |
$2K |
| 82525 |
|
464 |
414 |
$2K |
| 84154 |
|
542 |
454 |
$2K |
| 87906 |
|
27 |
25 |
$2K |
| 87210 |
|
717 |
571 |
$2K |
| 86645 |
|
176 |
150 |
$2K |
| 82575 |
|
416 |
336 |
$2K |
| 87076 |
|
555 |
431 |
$2K |
| 85246 |
|
182 |
168 |
$2K |
| 84160 |
|
1,689 |
1,443 |
$2K |
| 80358 |
|
1,149 |
466 |
$2K |
| 85384 |
|
507 |
419 |
$2K |
| 84478 |
|
1,335 |
705 |
$2K |
| 86644 |
|
181 |
152 |
$2K |
| 82085 |
|
889 |
693 |
$2K |
| 86060 |
|
344 |
292 |
$2K |
| 89055 |
|
791 |
712 |
$2K |
| 83993 |
|
110 |
104 |
$2K |
| 87185 |
|
723 |
572 |
$2K |
| 82164 |
|
300 |
260 |
$2K |
| 85306 |
|
275 |
215 |
$1K |
| 86668 |
|
74 |
68 |
$1K |
| 84166 |
|
186 |
152 |
$1K |
| 87140 |
|
342 |
279 |
$1K |
| 82679 |
|
115 |
105 |
$1K |
| 80355 |
|
2,357 |
756 |
$1K |
| 80321 |
|
1,180 |
1,007 |
$1K |
| 85245 |
|
116 |
104 |
$1K |
| 84590 |
|
286 |
255 |
$1K |
| 85303 |
|
251 |
209 |
$1K |
| 85390 |
|
238 |
214 |
$1K |
| 86765 |
|
208 |
184 |
$1K |
| 86256 |
|
246 |
118 |
$1K |
| 82553 |
|
231 |
207 |
$1K |
| 85049 |
|
740 |
592 |
$966.79 |
| 86735 |
|
166 |
140 |
$924.64 |
| 82239 |
|
101 |
72 |
$894.45 |
| 86692 |
|
57 |
46 |
$885.08 |
| 81050 |
|
472 |
393 |
$845.08 |
| 80373 |
|
1,156 |
378 |
$837.09 |
| 82747 |
|
169 |
141 |
$837.01 |
| 80345 |
|
331 |
202 |
$835.34 |
| 83835 |
|
136 |
121 |
$825.23 |
| 86790 |
|
55 |
46 |
$765.99 |
| 86880 |
|
337 |
299 |
$745.32 |
| 82157 |
|
55 |
52 |
$740.62 |
| 88173 |
|
20 |
14 |
$736.02 |
| 85300 |
|
153 |
134 |
$658.54 |
| 81374 |
|
28 |
24 |
$655.83 |
| 82103 |
|
125 |
106 |
$574.33 |
| 86317 |
|
158 |
28 |
$571.11 |
| 80347 |
|
32 |
24 |
$549.61 |
| 84300 |
|
481 |
441 |
$547.82 |
| 83519 |
|
108 |
84 |
$519.41 |
| 84482 |
|
84 |
79 |
$510.80 |
| 86337 |
|
32 |
32 |
$499.82 |
| 86617 |
|
104 |
59 |
$497.68 |
| 80323 |
|
265 |
158 |
$463.90 |
| 80337 |
|
39 |
25 |
$462.71 |
| 86777 |
|
87 |
76 |
$394.51 |
| 87290 |
|
58 |
42 |
$393.24 |
| 80366 |
|
989 |
326 |
$390.28 |
| 82270 |
|
247 |
207 |
$379.04 |
| 83789 |
|
65 |
46 |
$369.04 |
| 80299 |
|
13 |
13 |
$343.59 |
| 82390 |
|
80 |
65 |
$318.37 |
| 88302 |
|
14 |
12 |
$314.64 |
| 86702 |
|
145 |
94 |
$310.82 |
| G0328 |
Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous |
158 |
117 |
$241.50 |
| 80360 |
|
253 |
183 |
$232.56 |
| 80051 |
|
61 |
54 |
$232.50 |
| 85307 |
|
67 |
53 |
$231.48 |
| 88155 |
|
65 |
46 |
$229.71 |
| 84255 |
|
15 |
14 |
$228.44 |
| 86162 |
|
31 |
30 |
$226.65 |
| 80235 |
|
12 |
12 |
$222.99 |
| 86870 |
|
37 |
29 |
$218.88 |
| 86316 |
|
27 |
24 |
$211.51 |
| 87252 |
|
22 |
12 |
$209.70 |
| 86701 |
|
145 |
94 |
$204.04 |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
323 |
281 |
$203.59 |
| 87116 |
|
70 |
57 |
$202.32 |
| 86753 |
|
30 |
25 |
$197.96 |
| 82166 |
|
14 |
12 |
$193.50 |
| 80201 |
|
66 |
58 |
$184.48 |
| 89060 |
|
29 |
29 |
$178.61 |
| 83935 |
|
77 |
65 |
$171.90 |
| 84260 |
|
15 |
12 |
$169.42 |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
21 |
20 |
$150.00 |
| 85576 |
|
17 |
14 |
$147.18 |
| 82435 |
|
101 |
99 |
$143.07 |
| 83992 |
|
233 |
156 |
$139.69 |
| 88313 |
|
30 |
29 |
$139.57 |
| 82180 |
|
44 |
40 |
$138.53 |
| 87269 |
|
12 |
12 |
$131.57 |
| 82787 |
|
156 |
39 |
$126.38 |
| 87425 |
|
16 |
14 |
$115.44 |
| 83930 |
|
53 |
49 |
$108.34 |
| 84446 |
|
13 |
13 |
$107.50 |
| 85048 |
|
56 |
37 |
$104.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
20 |
19 |
$103.56 |
| 86707 |
|
27 |
24 |
$102.86 |
| 80371 |
|
211 |
146 |
$91.84 |
| 85230 |
|
16 |
12 |
$77.25 |
| 82374 |
|
55 |
52 |
$64.13 |
| 80173 |
|
20 |
15 |
$62.37 |
| 83014 |
|
16 |
13 |
$51.01 |
| 82540 |
|
36 |
30 |
$49.45 |
| 87497 |
|
13 |
12 |
$42.25 |
| 87385 |
|
15 |
12 |
$26.54 |
| 82340 |
|
12 |
12 |
$26.47 |
| 82955 |
|
12 |
12 |
$19.37 |
| 84145 |
|
18 |
17 |
$13.61 |
| 36416 |
|
119 |
81 |
$0.09 |
| 80369 |
|
200 |
139 |
$0.00 |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
26 |
12 |
$0.00 |
| 99000 |
|
3,513 |
2,720 |
$0.00 |
| 80368 |
|
205 |
141 |
$0.00 |
| 87483 |
|
48 |
19 |
$0.00 |
| 80188 |
|
32 |
26 |
$0.00 |